| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08 |
| filingDate |
1973-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a96097be742d2610ce9a5a087be196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1690433b780cce6fa9b5929e5aadc23 |
| publicationDate |
1975-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3862934-A |
| titleOfInvention |
3-Hydrazonomethyl rifamycins |
| abstract |
WHEREIN R is hydrogen or phenyl, R1 is phenyl or pcarboxyphenyl, and R and R1 taken together with the adjacent carbon atom may represent a 5 to 10 carbon atom cycloalkylidene group. The compounds are prepared by reacting 3-formylrifamycin SV or its 25-desacetyl or hexahydro derivative with a hydrazine of the formula 3-Hydrazonomethyl rifamycin compounds of the following formula and their 25-desacetyl and 16, 17; 18, 19; 28, 29-hexahydro derivatives: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0157444-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3024304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4271155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4150023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0157444-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4179439-A |
| priorityDate |
1972-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |